XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Operations and Comprehensive Income and Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Product revenue $ 11,200 $ 434 $ 22,105 $ 1,526
Cost of goods sold (1,640) (133) (4,062) (464)
Gross profit 9,560 301 18,043 1,062
Operating expenses:        
Research and development expenses 3,866 4,662 10,960 12,793
Selling, general and administrative expenses 6,953 6,195 22,532 15,147
Total operating expenses 10,819 10,857 33,492 27,940
Operating loss (1,259) (10,556) (15,449) (26,878)
Change in fair value of warrant liability 2,975 (9,384) (7,392) (8,224)
Interest expense, net 113 (395) (170) (1,454)
Other (expense) income 35 (5) 23 14
Net income (loss) 1,864 (20,340) (22,988) (36,542)
Other comprehensive (loss) income:        
Unrealized gain (loss) on investments (14) 0 (147) 0
Foreign currency translation adjustments 17 5 23 24
Total comprehensive income (loss) $ 1,867 $ (20,335) $ (23,112) $ (36,518)
Common share data:        
Basic income (loss) per common share (in dollars per share) $ 0.06 $ (1.14) $ (0.84) $ (2.61)
Weighted average number of basic shares outstanding (in shares) 28,738,307 17,863,078 27,335,212 13,985,248
Diluted income (loss) per common share (in dollars per share) $ 0.06 $ (1.14) $ (0.84) $ (2.61)
Weighted average number of diluted shares outstanding (in shares) 32,345,672 17,863,078 27,335,212 13,985,248